ALK Positive Lung Cancer Treatment Market
According to Intent Market Research, the ALK Positive Lung Cancer Treatment Market is expected to grow from USD 2.4 billion in 2023 at a CAGR of 10.4% to touch USD 4.9 billion by 2030. The ALK Positive Lung Cancer Treatment Market is dominated by key players such as, Novartis AG, Roche Holding AG, AstraZeneca Plc, Amgen Inc., and Merck & Co. Inc.